using rwd to evaluate the use of fedratinib as a potential bridge to hsct in patients with mf
Published 1 year ago • 58 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:06
fedratinib: mpn-associated myelofibrosis
-
5:24
krt‑232: first-in-class mdm2i for myelofibrosis r/r to jak inhibitor therapy
-
2:51
using human stem cell-derived hepatic organoids to model and correct fvii deficiency
-
1:20
to jaki or not to jaki - treating early mf
-
1:08
the benefits of car-t therapy in 2l over 3l in r/r dlbcl
-
2:21
driving quality of care for patients with blood clots | versiti blood research institute
-
4:14
artiflex toric step by step use of vacufix by dr. budo
-
3:45
fluid-air exchange
-
5:17
the evolving role of autologous transplantation in multiple myeloma
-
3:19
finding novel targets for myelofibrosis from animal models
-
1:28
vise project vault - manual surgical tool with robot-like dexterity
-
4:25
update on momelotinib for myelofibrosis
-
0:36
prevue™ ii vascular access system rollstand and boom arm
-
59:41
stored rbc transfusions: iron, inflammation, immunity, infection
-
12:52
microsoft released a method to quantize vectors (vptq)
-
2:32
vise doc walk
-
4:41:25
continuous decision-making
-
6:58
using "wall-to-wall" mechanical thrombectomy in dvt treatment
-
1:01
the veriti® thermal cycler from applied biosystems: get the power